Short Interest in NeueHealth, Inc. (NYSE:NEUE) Rises By 33.7%

NeueHealth, Inc. (NYSE:NEUE) was the target of a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 12,300 shares, an increase of 33.7% from the February 28th total of 9,200 shares. Based on an average daily volume of 47,300 shares, the short-interest ratio is presently 0.3 days. Currently, 0.5% of the shares of the company are short sold.

Insider Buying and Selling

In other NeueHealth news, CFO Jay Matushak sold 4,970 shares of the business’s stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $7.33, for a total value of $36,430.10. Following the completion of the sale, the chief financial officer now owns 17,747 shares of the company’s stock, valued at $130,085.51. The trade was a 21.88 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO George Lawrence Mikan III sold 26,660 shares of the stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $7.19, for a total transaction of $191,685.40. Following the transaction, the chief executive officer now owns 178,756 shares in the company, valued at approximately $1,285,255.64. The trade was a 12.98 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 110,033 shares of company stock valued at $774,560. Insiders own 64.30% of the company’s stock.

Institutional Trading of NeueHealth

A hedge fund recently bought a new stake in NeueHealth stock. Virtu Financial LLC bought a new position in shares of NeueHealth, Inc. (NYSE:NEUE) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 10,232 shares of the company’s stock, valued at approximately $76,000. Virtu Financial LLC owned approximately 0.12% of NeueHealth at the end of the most recent quarter. Hedge funds and other institutional investors own 63.88% of the company’s stock.

NeueHealth Trading Down 1.3 %

NEUE stock traded down $0.09 during mid-day trading on Monday, hitting $6.76. The stock had a trading volume of 29,622 shares, compared to its average volume of 19,936. The firm has a fifty day simple moving average of $6.95 and a 200 day simple moving average of $6.07. NeueHealth has a 52 week low of $3.79 and a 52 week high of $7.66. The firm has a market capitalization of $56.01 million, a P/E ratio of -0.13 and a beta of 0.56.

NeueHealth (NYSE:NEUE) last announced its quarterly earnings data on Thursday, March 20th. The company reported ($7.41) EPS for the quarter, missing the consensus estimate of ($2.29) by ($5.12). NeueHealth had a negative net margin of 36.28% and a negative return on equity of 6.40%. The firm had revenue of $232.64 million for the quarter, compared to analyst estimates of $261.80 million. As a group, equities analysts expect that NeueHealth will post -9.13 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, Royal Bank of Canada reduced their target price on NeueHealth from $8.00 to $7.00 and set a “sector perform” rating on the stock in a report on Monday, December 9th.

NeueHealth Company Profile

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.